How much does a box of Mirikizumab cost in 2025?

Mirikizumab (Mirikizumab)-Omvoh is a new biologic agent mainly used to treat autoimmune diseases, especially ulcerative colitis (UC). As a targeted antibody, militizumab reduces the inflammatory response by specifically inhibiting the activity of interleukin-23 (IL-23), thereby improving the clinical manifestations of patients. Studies have shown that the drug can effectively reduce symptoms of ulcerative colitis patients, such as abdominal pain, bloody stools and urgency to defecate, while also helping to repair damaged intestinal mucosa and improve patients' quality of life.

Ulcerative colitis is a chronic inflammatory bowel disease with complex causes and difficult treatment. Traditional treatment methods include the use of immunosuppressants and 5-aminosalicylic acid drugs, and militizumab, as a new biological agent, provides a new option for the treatment of this type of disease. In clinical trials, militizumab has shown good efficacy and safety, making it the focus of more and more doctors and patients.

Regarding the price of militizumab, since the original drug of this drug has not yet been launched in the Chinese market, the specific pricing is still unclear. In overseas markets, the common specifications of Militizumab are 300mg/15mL per tube, and it is expected that the selling price of each box may exceed RMB 10,000 (the price may fluctuate due to exchange rates). Therefore, patients should fully consider the financial burden when considering using this drug.

Militizumab has been on the market overseas for a relatively short time, and no generic drugs have yet been released, which makes the price of the drug likely to remain high in the short term. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.

Reference materials:https://www.ema.europa.eu/en/medicines/human/EPAR/omvoh